Colorectal Cancer Trial, Recruiting NCT07208786 Sponsor: Nanchong Central Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07208786
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with colorectal cancer through laboratory testing and are planned to have surgery to remove part of the colon or rectum.
  • People between 18 and 85 years of age who have been assessed by an anaesthetist as being in generally acceptable health for surgery (a standard pre-surgery health rating of I, II, or III).
  • People whose surgeon plans to reconnect the bowel in a single procedure during the same operation.
  • People, or their legal guardian, who are able to understand and sign a consent form and attend follow-up appointments.

Who may not be able to join:

  • People who already have a leak at a bowel join, or a serious infection inside the abdomen before surgery.
  • People who have a serious heart or brain condition that is currently in an acute or active stage, such as a recent heart attack or stroke.
  • People with severely reduced liver or kidney function, as measured by specific medical tests (confirm with trial site).
  • People with blood clotting problems — such as very low platelet levels or a high INR reading — or who are on blood-thinning medication that cannot be safely adjusted before surgery.
  • People who have previously had radiation treatment to the abdomen, or multiple past abdominal surgeries that have caused significant internal scarring.
  • People who have another type of cancer and are currently receiving radiation or chemotherapy for it.
  • People with a psychiatric condition or significant memory or thinking difficulties that would make it hard to follow the study requirements.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613508087719

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanchong Central Hospital
Registry
ClinicalTrials.gov
Start date
22 September 2025
Est. completion
10 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Number of Participants with Anastomotic Leak within 30 days

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov